We discuss two cases of hubs that are strongly involved in cancer: BRAF (Haling et al., 2014; Thevakumaran et al., 2015) and JAK2 (Bandaranayake et al., 2012), both with phenotypic pathogenic mutations occurring in ordered regions and affecting the disorder content of distal sites in the domain. This evidence concerns the gene JAK2 and cancer.